Clinical Trial Update: Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

View source ↗

Summary

The clinical trial evaluating breast cancer risk in BRCA1/BRCA2 mutation carriers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: BRCA1 Mutation Carrier, BRCA2 Mutation Carrier | Status: WITHDRAWN